Podcasts about early detection

EPISODE DESCRIPTIONLisa Shufro is the storyteller's storyteller. A musician turned innovation strategist, TEDMed curator, and unapologetic truth-teller, Lisa doesn't just craft narratives—she engineers constellations out of chaos. We go way back to the early TEDMed days, where she taught doctors, scientists, and technocrats how not to bore an audience to death. In this episode, we talk about how storytelling in healthcare has been weaponized, misunderstood, misused, and still holds the power to change lives—if done right. Lisa challenges the idea that storytelling should be persuasive and instead argues it should be connective. We get into AI, the myth of objectivity, musical scars, Richard Simmons, the Vegas healthcare experiment, and the real reason your startup pitch is still trash. If you've ever been told to “just tell your story,” this episode is the permission slip to do it your way. With a bow, not a violin.RELATED LINKSLisa Shufro's WebsiteLinkedInSuper Curious ArchiveEight Principles for Storytelling in InnovationStoryCorps InterviewCoursera Instructor ProfileWhatMatters ProjectFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

At 57, Ronnie was living a healthy, active life as a health coach, marathon runner, and triathlete. She had always taken great care of her health and never imagined that cancer would be part of her story—until June of 2018 after a routine colonoscopy, Ronnie was diagnosed with stage 4 colon cancer that had spread to liver, lungs, peritoneum and lymph nodes.   Faced with this grim prognosis, she chose to take an active role in her treatment. Ronnie opted for traditional chemotherapy but also incorporated naturopathic treatments into her regimen. Ronnie believed this combination would help support her body during the chemotherapy and aid in her healing. The journey wasn't easy, but the balance of conventional medicine and natural therapies helped her to stay strong and cope with the challenges she faced. Looking back, Ronnie realizes that her success wasn't just the result of traditional treatments or naturopathic therapies—it was her mindset, resilience, and refusal to give up. Cancer tried to take her life, but instead, it gave her a new one, one filled with gratitude, strength, and a deeper understanding of what truly matters. To learn more about Ronnie and her work visit, https://ronniecampbellauthor.com/ To purchase her book, Racing for a Miracle: A Stage 4 Survivor's Journey of Hope. Celebrating 5 Years Cancer-Free—A Story of Strength, Early Detection, and Miracles, visit https://ronniecampbellauthor.com/about-the-book/ Instagram @ronniecampbellauthor.com (https://www.instagram.com/ronniecampbell.author/) Facebook @ronnieswellness4life.com ( https://www.facebook.com/profile.php?id=100083650758740  )  Learn more about Colorectal Cancer Canada at https://www.colorectalcancercanada.com/ _________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com. To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube _____ Thank you to our friends from The Healing Oasis for sponsoring this episode of the podcast.  The Healing Oasis is a first of its kind in beautiful British Columbia, Canada where we encourage the body to heal from cancer using alternative therapies & cancer fighting meals at a wellness retreat center in nature. Our top naturopathic cancer doctor will prescribe a protocol tailored specifically for you. There's no place quite like it. Start your healing journey today! Learn More about The Healing Oasis by visiting these links: Website   Testimonials Video Overview

What happens when you blend the soul of Mr. Rogers, the boldness of RuPaul, and just a pinch of Carrie Bradshaw? You get Sally Wolf.She's a Harvard and Stanford powerhouse who ditched corporate media to help people actually flourish at work and in life—because cancer kicked her ass and she kicked it back, with a pole dance routine on Netflix for good measure.In this episode, we unpack what it means to live (really live) with metastatic breast cancer. We talk about the toxic PR machine behind "pink ribbon" cancer, how the healthcare system gaslights survivors when treatment ends, and why spreadsheets and dance classes saved her sanity. Sally doesn't just survive. She rewrites the script, calls out the BS, and shows up in full color.If you've ever asked “Why me?”—or refused to—this one's for you.RELATED LINKS:Sally Wolf's WebsiteLinkedInInstagramCosmopolitan Essay: "What It's Like to Have the 'Good' Cancer"Oprah Daily Article: "Five Things I Wish Everyone Understood About My Metastatic Breast Cancer Diagnosis"Allure Photo ShootThe Story of Our Trauma PodcastFEEDBACK:Like this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship inquiries, email podcast@matthewzachary.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

“A lot of other disease sites, they have some targeted therapies, they have some immunotherapies [IO]. In lung cancer, we have it all. We have chemo. We have IO. We have targeted therapies. We have bispecific T-cell engagers. We have orals, IVs. I think it's just so important now that, particularly for lung cancer, you have to be well versed on all of these,” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer treatment. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 16, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer treatments. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episode: Episode 359: Lung Cancer Screening, Early Detection, and Disparities ONS Voice articles: Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Oncology Drug Reference Sheet: Amivantamab-Vmjw Oncology Drug Reference Sheet: Cisplatin Oncology Drug Reference Sheet: Lazertinib Oncology Drug Reference Sheet: Nivolumab and Hyaluronidase-Nvhy Oncology Drug Reference Sheet: Fam-Trastuzumab Deruxtecan-Nxki Optimize Your Testing Strategy and Improve Patient Outcomes With NeoGenomics' Neo Comprehensive™–Solid Tumor Assay Clinical Journal of Oncology Nursing article: Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice Nurse ONS Biomarker Database ONS video: What is the role of the KRAS biomarker in NSCLC? Biomarker Testing in Non-Small Cell Lung Cancer Discussion Tool ONS Huddle Cards: Checkpoint inhibitors External beam radiation Monoclonal antibodies Proton therapy To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, because lung cancer is pretty aggressive, we'll see lung cancer mostly in stage IV. So about 50%–55% of all cases are not caught until they are already metastatic, or stage IV. And then about another 25%–30% of cases are caught in stage III, which means they're locally advanced and often not resectable, but we do still treat that with curative intent with concurrent chemoradiation. And then 10%–20% of cases are found in the early stage, and that's stage I and II, where we can do surgical approaches.” TS 2:53 “The majority of radiation that you're going to see is for patients with stage III disease that's inoperable. At my institution, a lot of stage III is inoperable. Now, neoadjuvant immunotherapy has changed that a little bit. But if you have several big, bulky, mediastinal lymph nodes that makes you stage III, surgery is probably not going to be a great option. So we give curative-intent chemoradiation to these patients.” TS 10:51 “Oligoprogression would mean they have metastases but only to one site. And sometimes we will be aggressive with that. Particularly, there's good data, if the only site of progression is in the brain, we can do stereotactic radiation to the brain and then treat the chest with concurrent chemoradiation as a more definitive approach. But outside of that, the majority of stage IV lung cancer is going to be treated with systemic therapy.” TS 15:00 “It's important for nurses to know that there's a lot of different options now for treatment. Probably one of the most important things is making sure patients are aware of what their biomarker status is, what their PD-L1 expression level is, and make sure those tests have been done. … It's good that the patients understand that there's a myriad of options. And a lot of that depends on what we know about their cancer, and then that guides our treatment.” TS 31:05

In this episode, we interview Christina Campero, an entrepreneurial force behind Prosperia, a tech startup focused on AI in healthcare. Christina discusses her professional journey, moving from a background in bioscience and healthcare consulting to co-founding Prosperia. The startup uses AI to scan retina images for early detection of diabetic retinopathy and other eye diseases, a crucial service in Mexico due to a high prevalence of diabetes and limited access to ophthalmologists. The conversation covers the development process of their AI model, partnerships with primary healthcare touchpoints, and the advantages of operating in Mexico. They also explore the challenges and breakthroughs in fundraising for a Latin American AI healthcare startup, including securing a seed round from a Swedish fund. The episode ends with a look at Prosperia's future goals, including expanding their AI applications to detect other health conditions.   If your company is looking to scale its AI initiatives, head over to Tesoro AI (www.tesoroai.com). We are experts in AI strategy, staff augmentation, and AI product development.   Founder Bio:   Cristina Campero graduated from the Faculty of Chemistry of the UNAM with a Master's Degree in Bioscience Enterprise from the University of Cambridge in the United Kingdom. She has dedicated her professional career to the transformation of ideas into commercial products with an impact on health, starting in her career as a consultant at McKinsey & Company and in start-ups, first as an Associate in business development and strategy at Wren Therapeutics (in Cambridge UK ) where she was in charge of portfolio prioritization and funding (£18M Series A in Dec. 2018), and now as CEO of PROSPERiA.      Time Stamps:   00:36 Christina's Professional Journey 04:00 Founding Prosperia and Developing Retinia 05:43 Addressing Diabetic Retinopathy with AI 07:10 Challenges in Diabetic Retinopathy Detection 09:32 AI's Role in Early Detection and Screening 13:33 How does the Retinia software diagnosis work 15:20 The role of AI versus human doctors 20:43 Building and Training AI Models 24:31 Balance between engineers and health care professionals 26:14 Creating a customer base that trusts AI diagnosis 32:53 Fundraising and Growth Strategies 40:45 Advantages of Fundraising in Latin America Compared to the U.S. 44:01 Future Plans and Innovations   Resources   Follow Darius Gant LinkedIn - https://www.linkedin.com/in/m-darius-gant-cpa-44650aa/ Company Website - www.tesoroai.com     Subscribe on Spotify: https://open.spotify.com/show/4uDVNgsK3iNeu7yU4Inu2n   Subscribe on Apple Podcast: https://podcasts.apple.com/ae/podcast/the-darius-gant-show/id1527996104   Company website: https://www.prosperia.health/es LinkedIn: https://www.linkedin.com/company/prosperia/ https://www.linkedin.com/in/cristina-campero-peredo-a87a15115/  

Dr. Dale Bredesen, a renowned expert in the field of neurodegenerative diseases, is on a mission to reshape the way we think about aging and brain health. He challenges conventional perceptions about aging, emphasizing the importance of maintaining a "brain span" that matches one's lifespan. Often posing thought-provoking questions about longevity, Dr. Bredesen highlights the undesirability of living to an advanced age if it means suffering from dementia. His work, driven by ongoing research and encapsulated in his latest book, aims to shift the narrative from expecting cognitive decline with age to implementing proactive strategies for preserving brain function. Timestamps: 05:24 Brain Health Over Longevity 07:53 Exercise, Memory, and APOE4 Gene Impact 10:26 Optimizing Cognition: Early Detection's Role 14:56 Herpes and Toxins Linked to Cognitive Decline 17:38 Neurotransmitters, Choline, and Stress Impact 20:43 Tau's Role in Brain Health 24:57 Understanding Cognitive Health Markers 26:43 Misdiagnosed Alzheimer's Story 30:51 Optimal Diet and Fasting Guidelines 33:35 Expanding Exercise Benefits in Neurology 39:11 Early Detection in Alzheimer's Prevention

Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including:Why early detection is key for improving patient outcomesHow to monitor through use of noninvasive imaging and biopsy per guideline recommendationsHow to coordinate patient care to provide much-needed multidisciplinary careWhat therapies in the pipeline could transform the treatment landscape for this genetic disease PresentersPaula Henao, MDAssistant Professor of MedicineDivision of Pulmonary, Allergy and Critical Care MedicinePenn State Hershey Medical CenterHershey, PennsylvaniaRohit Loomba, MD, MHScProfessor of MedicineChief, Division of Gastroenterology and HepatologyDirector, MASLD Research CenterUniversity of California, San DiegoSan Diego, CaliforniaCheryl Pirozzi, MD, MSAssociate Professor of Internal MedicineDivision of Pulmonary and Critical Care MedicineUniversity of UtahSalt Lake City, UtahCorinne Young, NP, FCCPPresident/FounderAssociation of Pulmonary Advanced Practice ProvidersColorado Springs, ColoradoLink to full program: https://bit.ly/4dgCRnq

Send us a textMark McDonough is the CEO of Cyrex Labs ( https://www.cyrexlabs.com/ ), a clinical immunology laboratory specializing in functional immunology and autoimmunity testing. Cyrex offers multi-tissue antibody testing for the early detection and monitoring of today's complex autoimmune conditions and develops innovative arrays through continuous collaboration with leading experts in medical research and clinical practice.Mark is a global technology business executive with 30 years of experience, and his personal mission is to impact change in the field of healthcare in a compassionate yet resolute manner, leading by example.Prior to Cyrex, Mark served in several private and public company CEO roles including PierianDx and CombiMatrix, a publicly held molecular diagnostics company performing DNA-based testing services for reproductive health, oncology, and developmental disorders.Earlier in his career, Mark served in various sales leadership roles at high growth diagnostic companies to include Ventana Medical Systems (acquired by Roche) and US LABS (acquired by LabCorp). Mark is married with three children and is a proud former Naval Officer having served as a Navigator and Communications Officer on the USS FLETCHER (DD 992).#MarkMcDonough #CyrexLabs #ClinicalImmunology #FunctionalImmunology #Autoimmunity #AristoVojdani #FoodAssociatedAutoimmunities #Neuroimmunity #BrainGutConnection #LifestyleMedicine #Antigenic #Inflammation #MolecularMimicry #ImmuneReactivity #PathogenAssociatedImmuneReactivity #MultipleChemicalSensitivities #MicrobialTransglutaminase #CeliacDisease #NonCeliacGlutenSensitivity #CrohnsDisease #Neuroautoimmunity #Neurodegeneration #BloodBrainBarrier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast #STEM #Innovation #Science #Technology #ResearchSupport the show

Is there a blood test for Alzheimer's? What causes colon cancer? How many measles cases in 2025? Is bird flu still an issue? What outbreaks are happening right now? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the first measles cases of the year in new U.S. cities, and avian flu outbreaks in dairy cattle and poultry. Also discussing a recent survey on Alzheimer's disease and new research suggesting links between gut bacteria and colon cancer in younger adults. American Medical Association CXO Todd Unger hosts.

Could our healthcare system be making us sicker rather than healthier? In the UK, autism diagnoses have increased by a staggering 787% between 1998 and 2018, and one in five people now has some form of mental health disorder. But what if some of our health struggles aren't diseases to be cured, but normal human experiences being medicalised? This week, I'm joined by Dr Suzanne O'Sullivan, a consultant in clinical neurophysiology and neurology at The National Hospital for Neurology and Neurosurgery, who specialises in the investigation of complex epilepsy and also has an active interest in psychogenic disorders.  Her latest book, The Age of Diagnosis: Sickness, Health, and Why Medicine Has Gone Too Far, aims to challenge long-held assumptions about medical progress and change the way we think about our health.  In this thought-provoking conversation, we explore: Why giving someone a diagnosis is never neutral – it can fundamentally change how a person views themselves, their body and their future possibilities How the definition of autism has dramatically expanded over the past few decades from its original concept of "extreme autistic aloneness" to now potentially including 1 in 20 children in Northern Ireland Why screening for diseases like prostate cancer can lead to unnecessary treatment The potential problems of genetic testing - when results are misinterpreted or used without proper context, especially with tests that aren't clinical grade Why early detection and treatment aren't always better, particularly when it turns healthy people into patients decades before they might develop symptoms The profound story of how Suzanne diagnosed a rare genetic condition in a 15-year-old girl, only to question whether she had actually done the right thing by medicalising someone who believed herself to be healthy This is a nuanced, compassionate discussion that challenges many of the widely held assumptions in modern healthcare and I would urge you to listen with an open mind. Throughout our conversation, Suzanne emphasises that she's not arguing against the existence of these conditions or suggesting everyone should refuse diagnosis. Rather, she encourages both patients and doctors to consider whether medicalising our struggles is always the right approach. I hope you enjoy listening.   Support the podcast and enjoy Ad-Free episodes. Try FREE for 7 days on Apple Podcasts https://apple.co/feelbetterlivemore.  For other podcast platforms go to https://fblm.supercast.com.   Thanks to our sponsors: https://thriva.co https://drinkag1.com/livemore https://vivobarefoot.com/livemore https://airbnb.co.uk/host   Show notes https://drchatterjee.com/553   DISCLAIMER: The content in the podcast and on this webpage is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on my website.

Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening.  This technology can help reduce unnecessary biopsies and additional tests while more accurately identifying cancers that need immediate attention. The concerning trend of rising breast cancer in younger women highlights the importance of early detection and personalized care plans. Dana explains, "Literally, iCAD's first FDA-cleared product in a first-generation AI was around 2002. So it's been well over 20 years. We're now on our fourth generation. So, yes, you're very accurate in describing this as a next-generation approach. So, not only has imaging technology improved over the past 20 years, but artificial intelligence has also improved. We continue to leverage the latest in artificial intelligence technology, how the artificial intelligence can be trained and learn, and a broad base of researchers that help us develop the solution. So you have new minds, new ways to think about solving the problem, and new technology that can be used to solve the problem. Then, there is a new underlying screening technology that gets better and better at clearer imaging." "The American Cancer Society reports that if we can catch a breast cancer very early in stage one, then the likelihood of, I'll say surviving breast cancer is 99%, so very, very high. So the earlier we can catch a breast cancer, the less invasive and costly and length of time the treatments can be. There are more options for those patients as well as the likelihood of a positive outcome, being able to again, have no further evidence of the disease is increased." #iCAD #BreastCancer #BreastCancerScreening #Radiology #CancerDetection #BreastBiopsies #Mammogram #WomensHealth #MedAI icadmed.com Download the transcript here

Dana Brown serves as President, CEO, and Chairman of the Board at iCAD Inc., which has developed a next-generation approach that leverages advancements in AI and imaging technology to improve the accuracy and efficiency of breast cancer screening.  This technology can help reduce unnecessary biopsies and additional tests while more accurately identifying cancers that need immediate attention. The concerning trend of rising breast cancer in younger women highlights the importance of early detection and personalized care plans. Dana explains, "Literally, iCAD's first FDA-cleared product in a first-generation AI was around 2002. So it's been well over 20 years. We're now on our fourth generation. So, yes, you're very accurate in describing this as a next-generation approach. So, not only has imaging technology improved over the past 20 years, but artificial intelligence has also improved. We continue to leverage the latest in artificial intelligence technology, how the artificial intelligence can be trained and learn, and a broad base of researchers that help us develop the solution. So you have new minds, new ways to think about solving the problem, and new technology that can be used to solve the problem. Then, there is a new underlying screening technology that gets better and better at clearer imaging." "The American Cancer Society reports that if we can catch a breast cancer very early in stage one, then the likelihood of, I'll say surviving breast cancer is 99%, so very, very high. So the earlier we can catch a breast cancer, the less invasive and costly and length of time the treatments can be. There are more options for those patients as well as the likelihood of a positive outcome, being able to again, have no further evidence of the disease is increased." #iCAD #BreastCancer #BreastCancerScreening #Radiology #CancerDetection #BreastBiopsies #Mammogram #WomensHealth #MedAI icadmed.com Listen to the podcast here

Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive testing, access to neurologists, and education on lifestyle changes that can support a good quality of life. Their mission is to take a proactive rather than the current reactive approach to diagnosing and slowing the progression of cognitive decline.   Rany explains, "The challenge for us, and this is what I saw from years of clinical practice and hospital management, is that a disease like Alzheimer's operates almost like a green light. Life is okay, you're having minor issues, but for the most part, you're moving along. Then suddenly you notice a sentinel event, which then becomes that red light, and now you have Alzheimer's dementia. And so the issue that is at the core of Alzheimer's is early detection. Is there a way for us to detect things earlier and, in turn, provide patients with an opportunity to take control of their dementia and make the necessary changes in treatments?" "In the current setting, the way that we do it in the United States and around the world is really reactive and it is too late by the time your mother or father is developing cognitive complaints. It's very easy to ignore the early stages of it because you can function for three to five years without really anything dramatic happening. So suddenly, when that dramatic instance occurs, for example, you leave the stove on, or you get lost driving back to your house, something that's very obviously outside of the normal, that might trigger you to say, "Let's get Mom checked." "At launch, our focus is on using the biomarker called p-tau 217. This biomarker can be detected now with more technologies in the blood at microscopic levels, and we couldn't do that effectively 10 or 15 years ago. That science has caught up, and the technology has caught up to a point that now, even 8 to 10 years before any significant clinical symptoms occur, we're able to detect if this protein is elevated. Now, if this protein is elevated, depending on the assay that we use, it's about 93%-97% sensitive for potentially developing Alzheimer's long-term. So it's a good protein to use as a triage protein." #NeurogenBiomarkings #Biomarkers #BloodBiomarkers #Alzheimers #AlzheimersDisease #CognitiveDecline #Dementia #EarlyDetection #Neurologists NeurogenBiomarking.com Download the transcript here 

Dr. Rany Aburashed, CEO and Founder of Neurogen Biomarking, is using a blood-based biomarker looking at p-tau 217 to detect early signs of Alzheimer's disease, up to 8-10 years before the onset of clinical symptoms. The company has built an ecosystem to provide patients with a comprehensive health assessment with an at-home blood test, cognitive testing, access to neurologists, and education on lifestyle changes that can support a good quality of life. Their mission is to take a proactive rather than the current reactive approach to diagnosing and slowing the progression of cognitive decline.   Rany explains, "The challenge for us, and this is what I saw from years of clinical practice and hospital management, is that a disease like Alzheimer's operates almost like a green light. Life is okay, you're having minor issues, but for the most part, you're moving along. Then suddenly you notice a sentinel event, which then becomes that red light, and now you have Alzheimer's dementia. And so the issue that is at the core of Alzheimer's is early detection. Is there a way for us to detect things earlier and, in turn, provide patients with an opportunity to take control of their dementia and make the necessary changes in treatments?" "In the current setting, the way that we do it in the United States and around the world is really reactive and it is too late by the time your mother or father is developing cognitive complaints. It's very easy to ignore the early stages of it because you can function for three to five years without really anything dramatic happening. So suddenly, when that dramatic instance occurs, for example, you leave the stove on, or you get lost driving back to your house, something that's very obviously outside of the normal, that might trigger you to say, "Let's get Mom checked." "At launch, our focus is on using the biomarker called p-tau 217. This biomarker can be detected now with more technologies in the blood at microscopic levels, and we couldn't do that effectively 10 or 15 years ago. That science has caught up, and the technology has caught up to a point that now, even 8 to 10 years before any significant clinical symptoms occur, we're able to detect if this protein is elevated. Now, if this protein is elevated, depending on the assay that we use, it's about 93%-97% sensitive for potentially developing Alzheimer's long-term. So it's a good protein to use as a triage protein." #NeurogenBiomarkings #Biomarkers #BloodBiomarkers #Alzheimers #AlzheimersDisease #CognitiveDecline #Dementia #EarlyDetection #Neurologists NeurogenBiomarking.com Listen to the podcast here 

What inspires individuals to turn personal battles into advocacy for others' health? The Hats and Henna High Tea event, born from Ashma Khanani-Moosa's breast cancer journey, has become a beacon of awareness and support through its empowering initiatives. Attendees, including survivors like Mona Ellakany and healthcare professionals, emphasize the significance of early detection and community support in conquering breast cancer. Their shared stories highlight the power of resilience and collective encouragement in overcoming life's toughest challenges. Key Questions Answered 1. What is the purpose of The Rose's Hats and Henna High Tea event? 2. Why is it important to subscribe to the podcast and share it with others? 3. How did Tina Saenz get connected with The Rose, and why is breast cancer prevention important to her? 4. What message does Mona Ellakany have for women battling breast cancer? 5. How did Mazin Ellakany support his mother during her breast cancer journey? 6. What is Yang’s perspective on the importance of convenient access to preventive care? 7. Why does Dr. Abdul Moosa emphasize the importance of early detection and mammography? 8. What contributions has Linlin Yan made to raise awareness of breast cancer in the community? 9. How does Dr. Zainab Alawadi approach the first meeting with a patient diagnosed with breast cancer? 10. How has Kareem Mohammed’s personal experience shaped his view on early cancer detection and support? Timestamped Overview 00:00 Embrace Cancer as a Journey 04:57 Mobile Mammography For Early Detection 09:14 Breast Cancer: Challenges and Support 12:05 Early Detection and Support Crucial Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

There are calls for a fundamental shift in how we deal with Coronary Artery Disease is understood and dealt with. the importance of early detection of heart disease with Dr. Róisín Colleran, Consultant Cardiologist at Mater Private Network in Dublin.

In this episode, I'm joined by Dr. Dale Bredesen, a true pioneer in Alzheimer's research and functional medicine. Together, we dive into groundbreaking advancements in the world of neurodegenerative diseases, with a special focus on the exciting breakthroughs in detecting and potentially reversing Alzheimer's and other related conditions. Dr. Bredesen sheds light on the new disease mechanisms and innovative blood tests that are changing the game, showing us that cognitive decline isn't something we simply have to accept. We also explore his integrative approach to combating Alzheimer's, which includes lifestyle modifications, early detection, and a holistic strategy for better brain health. This conversation is packed with hope and real strategies for a future where Alzheimer's doesn't have to be inevitable. Key Takeaways: New Era of Research: Alzheimer's and similar neurodegenerative diseases are not death sentences, thanks to innovative research and new treatment protocols that emphasize early detection and intervention. Significance of Gut Health: Investigations reveal that gut microbiota and inflammation are crucial risk factors in cognitive decline, underscoring the importance of gut health in preventing Alzheimer's. Role of Lifestyle Changes: Diet, exercise, sleep, and stress management are integral to maintaining brain health and can significantly influence the progression of neurodegenerative diseases. Advance in Diagnostics: Cutting-edge blood tests such as P Tau217 and brain scans can detect early signs of Alzheimer's up to 20 years prior to diagnosis, offering opportunities for preemptive action. The Power of Personalized Medicine: Individualized protocols based on genetic testing, like assessing APOE status, are pivotal in developing effective prevention and treatment strategies for cognitive disorders. More About Dr. Dale Bredesen: Dr. Dale Bredesen, M.D., is a globally recognized expert in neurodegenerative diseases, particularly Alzheimer's disease. With a background that includes graduating from Caltech and earning his M.D. from Duke University Medical Center, Dr. Bredesen's career is marked by groundbreaking research and clinical expertise. He completed his residency as chief resident in neurology at UCSF and further honed his skills at Nobel laureate Stanley Prusiner's lab at UCSF as an NIH postdoctoral fellow. Dr. Bredesen's academic career includes faculty positions at prestigious institutions like UCSF, UCLA, and UC San Diego. As the founding president and CEO of the Buck Institute for Research on Aging, he spearheaded pioneering work in the study of aging and neurodegenerative diseases. Currently, he serves as the chief medical officer of MPI Cognition, where he continues his innovative research and efforts to combat Alzheimer's and related conditions. Dr. Bredesen's expertise and leadership have made him a key figure in the field, with a focus on integrative approaches to prevent and reverse cognitive decline. His contributions are reshaping our understanding of neurodegenerative diseases, offering new hope for those affected by them. Website Instagram Take a Cognitive Assessment here: https://www.apollohealthco.com/know-your-cq/ Get a brain scan: https://getabrainscan.com/ KetoFLEX 12/3: https://www.trifectanutrition.com/apollohealthpartner Connect with me! Website Instagram Facebook YouTube   This episode is sponsored by Professional Co-op®, where clinicians gain exceptional access to industry-leading lab services without the hefty price tag—since 2001, they've been redefining what efficient, patient-focused support looks like. Imagine no hidden fees, no minimums, and only paying for completed tests. Experience lab services that not only meet but also exceed your expectations. Join the co-op trusted by countless licensed clinicians nationwide. Visit www.professionalco-op.com to learn more! This episode is also made possible by Functional Medicine University. FMU is a fully online, self-paced training program in functional medicine, founded in 2006 by Dr. Ron Grisanti. With students in all 50 U.S. states and 68 countries globally, FMU has become a cornerstone in advanced clinical education for healthcare practitioners. The curriculum is led by Dr. Grisanti, alongside contributions from over 70 distinguished medical experts on FMU's advisory board. Graduates earn the prestigious Certified Functional Medicine Practitioner (CFMP®) credential upon completion. FMU is also a nationally approved provider of continuing education for a wide range of licensed professionals, including MDs, DCs, DOs, NDs, acupuncturists, PAs, NPs, nurses, dietitians, pharmacists, and dentists. Whether you're looking to expand your clinical knowledge or bring a functional approach to your practice, FMU offers the tools, guidance, and certification to help you thrive. Visit www.functionalmedicineuniversity.com to learn more!

Episode 359: Lung Cancer Screening, Early Detection, and Disparities “I was actually speaking to a primary care audience back a few weeks ago, and we were talking about lung cancer screening. And they said, ‘Our patients, they don't want to do it.' And I said, ‘Do you remind them that lung cancer is curable?' Because everybody thinks it is a death sentence. But when you're talking about screening a patient, I think it's really important to say, ‘Listen, if we find this early, stage I or stage II, our chances of curing this and it never coming back again is upwards of 60% to 70%,'” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer screening. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 18, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer screening. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 313: Cancer Symptom Management Basics: Other Pulmonary Complications Episode 295: Cancer Symptom Management Basics: Pulmonary Embolism, Pneumonitis, and Pleural Effusion Episode 247: Tobacco Treatment for Patients With Cancer ONS Voice articles: Lung Cancer Screening and Early Detection Drastically Improves Survival Rates Pack-Year History Is a Biased and Inadequate Criterion for Lung Cancer Screening Eligibility, Researchers Say CMS Expands Eligibility Criteria for Lung Cancer Screening With Low-Dose Computed Tomography Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Clinical Journal of Oncology Nursing articles: Nurse-Led Tobacco Cessation for Veterans Using Motivational Interviewing in a Lung Cancer Screening Program Identifying Primary Care Patients at High Risk for Lung Cancer: A Quality Improvement Study Oncology Nursing Forum article: Patient–Provider Discussion About Lung Cancer Screening Is Related to Smoking Quit Attempts in Smokers ONS Tobacco, E-Cigarettes, and Vaping Learning Library American Cancer Society Lung Cancer Screening Guidelines American Lung Association lung cancer resources To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, the current state of lung cancer screening is pretty low. Our rate of uptake in eligible patients is somewhere between 6% and 20%. And that falls much further below what we see for screening, such as breast cancer screening, prostate cancer screening, and colorectal cancer screening. So certainly, we can do better.” TS 1:32 “If you quit more than 15 or 20 years, your risk of developing lung cancer at that point is significantly lower. And so that's why once patients have quit more than 15 years, they're actually not eligible for screening anymore—because their risk of developing lung cancer is dramatically reduced. And that takes into account when you are a primary care provider, pulmonary, whatever field you work in, and you are running a screening clinic each year that you screen the patient, you have to remind yourself when they quit smoking, because once they reach that 15 years, then they're no longer eligible for screening.” TS 5:17 “One of the strategies that they've used to get the word out is, I watch a lot of baseball. I love the Philadelphia Phillies, watch Phillies games. And so at least once a year, maybe even twice a year, they will take an inning of the baseball broadcast on TV and on the radio separately, and they will bring on either an oncologist or pulmonologist from one of the local cancer centers in our area, and the whole inning—between batters of course—they will talk about lung cancer screening and why it's beneficial.” TS 13:16 “Medicare always has its idiosyncrasies. So Medicare—I went over the rules with you, so the age, the smoking. They follow all of it, except they have a slight difference in age. They cover it for age 50 to 77, as opposed to 80.” TS 16:52 “I think just the other thing that people don't think about is that to go get a medical test done, no matter what test it is, typically people have to take time off of work. And it can be really hard to do that when you are relying on your job, maybe you don't have vacation time, maybe you have children at home that you need to get home to. When people are weighing the risk/benefit and thinking, ‘Well, I'd love to get screened for lung cancer, but I just can't find time to fit it into my schedule, and my job won't let me take off.' These are all things that we don't always think about if you have the luxury of just taking the day off.” TS 20:01

What inspires a company's commitment to community support and engagement? Michael Bland, Capital Project Stewardship Leader at Celanese, illustrates how their proactive approach led them to The Rose, supporting its mission through donations and involvement. From providing much-needed chemo kits to actively participating in community events, Celanese has become a partner rather than just a donor. Their employees, driven by values and empowered by the organization, strive to make a profound impact in the community. Key Questions Answered 1. What is Michael Bland's role at Celanese? 2. What does Michael enjoy most about his job at Celanese? 3. Can you explain what Celanese does as a company? 4. How did Celanese first become involved with The Rose? 5. What kind of community support has Celanese provided to The Rose? 6. Who did Michael Bland dress up as for the Shrimp Boil's 80s costume contest? 7. How did the Celanese team participate in the Shrimp Boil event? 8. What was the significance of the survivor's quilt mentioned in the episode? 9. How does Celanese view its role in community involvement, according to Michael Bland? 10. What is the "Keep the Mobile on the Road" program mentioned by Dorothy Gibbons? Timestamped Overview 00:00 "Breast Health Podcast: Community Support" 04:48 Celanese's Commitment to Community 07:11 Dressing as Slash and Axl, 1986 09:44 Affordable Shrimp Fundraiser & Community Event 14:15 Shared Enthusiasm Impresses New Visitor 16:51 Breaking Silence for Early Detection 21:09 Underestimated Support Logistics 22:13 Mobile Repair Fundraiser Program 25:14 Donations Support Trauma Recovery ProgramSee omnystudio.com/listener for privacy information.

In Module 2 of this podcast series, discover strategies for developing personalized management plans for patients with systemic mastocytosis (SM), a rare disease with a wide spectrum of symptoms. This episode highlights the latest advancements in treatment, including tyrosine kinase inhibitors (TKIs), supportive care interventions, and approaches to tailoring therapies based on disease subtype and symptom burden to improve patient outcomes and quality of life. Listen now! Click here to claim credit for this activity: bit.ly/43VoFNP

HEALTH NEWS   Study Finds Green Tea may Heal Neurodegenerative Conditions like Alzheimer's High blood pressure? Eat more bananas Mediterranean diet and exercise may slow bone loss in aging women Can gut microbes help prevent Alzheimer's? Radiation from CT scans could account for 5% of all cancer cases a year, study suggests Thermography is Key for Early Detection of Breast Cancer  

In Module 1 of this podcast series, explore the challenges of diagnosing systemic mastocytosis (SM), a rare and often underdiagnosed mast cell disease. This episode delves into the diverse symptoms of SM—ranging from anaphylaxis and cutaneous issues to gastrointestinal, neuropsychiatric, and musculoskeletal manifestations—and provides essential insights into recognizing the signs, confirming the diagnosis, and improving patient outcomes through early intervention. Listen now! Click on the link to claim your credit now: bit.ly/3Y3ivHM Click here to continue listening to Module 2 of this podcast series: bit.ly/43VoFNP

Guest: Jordan Orange, MD, PhD Guest: Joshua Milner, MD Guest: Eric Silver, MD Guest: Steven Lobritto, MD On this episode of Advances in Care, host Erin Welsh explores the story behind the GUARDIAN study, where thousands of newborn babies have been screened against rare disease by sequencing their genes, and looking for more conditions than any of the current standard screening panels. First, she hears from Dr. Jordan Orange, Physician-in-Chief at Morgan Stanley Children's Hospital at NewYork-Presbyterian and Columbia, about why genetic testing is a promising way of not only catching treatable rare diseases in infants, but also expanding health equity and medical resources to marginalized populations. Erin also hears from Dr. Josh Milner, a pediatric immunologist who treated a patient with a rare form of SCID, or severe combined immune deficiency, also known as bubble boy disease that was detected in the GUARDIAN screening panel. SCID is a disease that typically occurs in 1 of 50,000 babies. But GUARDIAN caught two cases within the first 10,000 babies involved in the program, indicating that the rate of the disease might be higher than expected, and that the most accurate way to detect is through genetic screening. Dr. Steven Lobritto, a pediatric gastroenterologist, also weighs in on how genetic screening can help identify Wilson's disease, a copper storage …

Early Detection and Early Intervention - where are we now (and what does the future hold)?The last time we had Alicia on the pod, we spoke about the Cochrane Review she led titled “Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants” which was published in 2024. In this week's episode, we thought we'd ask Alicia about the state of early intervention right now and what the provision of therapy looks like within our current context of early detection and early intervention for children with cerebral palsy.There have been some rather significant developments in the early detection and early intervention space over the past 20 years. From the rapid technological advances to the value of co-design and involvement of people with lived experience, we now have some impressive evidence to guide our clinical pathways. However, what is very clear now is the vital importance of implementation. The industry has generated substantial knowledge that now needs to be implemented into practice with one particularly important aspect that we must include - family involvement and well-being. Alicia speaks ever so passionately about our role as therapists and I cannot help but to feel even more compelled to ensure that the family is at the centre of everything we do. It is exciting to know that we have the evidence now, so it's time to put it into practice and it can start in your very next session.https://findanexpert.unimelb.edu.au/profile/27041-alicia-spittle

Craig Cooper, former professional athlete and author of Your New Prime, shares the overlooked realities men face as they age. He opens up about reversing his own osteoporosis and why many men fail to prioritize bone health. Craig breaks down why typical fitness routines may actually accelerate aging and offers science-backed alternatives for maintaining strength, metabolic function, and cardiovascular resilience. This episode equips listeners with practical, often ignored insights into how to stay strong, capable, and engaged well beyond midlife.This May 26-31 in Santa Fe, NM, Rebecca Rusch and AGEIST founder David Stewart are hosting what might be the most transformative week of your year. It's what Rebecca calls "adult play summer camp," blending cutting-edge science with genuine joy.Ideal for all fitness levels – whether you're a seasoned athlete or just getting started on your wellness journey.Ready to feel better than you have in years? Your future self is waiting at meawisdom.com/enrollThanks to Our SponsorsBON CHARGE: What if there was a device that combined nature's beneficial frequencies with red, near-infrared, and far-infrared light? BON CHARGE's Infrared PEMF Mat Max is the all-in-one device that can help you recover faster, sleep better, elevate your focus, and achieve ultimate wellness. Use “AGEIST15” at checkout for 15% off your purchase.Timeline Nutrition: Our favorite supplement for cell support and mitochondrial function. Listeners receive 10% off your first order of Mitopure with the code “AGEIST” at TimelineNutrition.com/ageist.Our Place: Our top cookware brand for non-toxic, PFA-free pots and pans. Use code “AGEIST” for 10% off at fromourplace.com.Chapters(00:15) Introduction to Craig Cooper and His Journey(06:42) The Evolution of Health Perspectives in Aging(13:04) Bone Health: Overcoming Osteopenia(17:29) Cardiovascular Health and Longevity(24:48) Nutrition and Dietary Choices for Better Aging(26:57) Understanding Cardiovascular Health Tests(33:04) The Importance of Early Detection in Health(36:12) Cardiovascular Disease: The Leading Cause of Death(40:52) Practical Health Monitoring Tips(42:54) The Role of Personal Responsibility in Health(46:20) Inspiring Stories of Resilience and Health(52:12) Nutritional Strategies for Bone HealthKey Moments“Hormonally, [training] long slow distance just really just sucks your manhood.”“You really can't have a discussion around longevity without focusing on arterial health.”“I've had doctors come out of UCLA to look at what I've been doing… they've never seen this sort of switch that I've been able to execute on my bone health over the course of five years.”Connect With Craig CooperConneqt Health: conneqthealth.comLinkedIn: https://www.linkedin.com/in/craigcooper007/Say hi to the AGEIST team!

Have you or someone you love been impacted by a cancer diagnosis, scare or otherwise? Unfortunately, that is the reality of so many of us today. In this crucial episode of Millennial Mind, I sit down with Dr. Ranj, an NHS clinician, author, and columnist, to discuss the importance of early detection and awareness of cancer symptoms. With statistics showing that one in two people will likely get cancer in their lifetime, this conversation emphasises why recognising early signs such as unexplained weight loss, excessive night sweats, new lumps, or persistent skin changes is vital for better outcomes. We also touch upon cultural barriers, especially within South Asian communities, and the impact of stigma and embarrassment in delaying diagnosis. Our goal is to reassure and encourage everyone to seek medical advice promptly for any concerning symptoms. For more information, visit nhs.uk/cancer-symptoms. Don't miss this informative and potentially life-saving discussion. 00:00 Understanding Cancer: Early Diagnosis and Survival Rates 00:58 Introduction to the Podcast and Guest 02:43 The NHS Help Us, Help You Campaign 04:14 Cultural Barriers and Embarrassment in Cancer Diagnosis 09:43 Early Signs and Symptoms of Cancer 14:23 Causes and Risk Factors of Cancer 16:32 Dietary Habits and Cancer Awareness in South Asian Communities 21:03 Understanding Cancer in Different Age Groups 21:42 The Complexity of Cancer Causes 23:17 Risk Factors and Screening Programs 25:24 The Importance of Early Detection 28:42 Cultural Barriers and Misconceptions 31:57 Encouraging Health Conversations in Families 34:48 General Health Advice and Prevention 37:50 Final Thoughts and Resources

Have you or someone you love been impacted by a cancer diagnosis, scare or otherwise? Unfortunately, that is the reality of so many of us today. In this crucial episode of Millennial Mind, I sit down with Dr. Ranj, an NHS clinician, author, and columnist, to discuss the importance of early detection and awareness of cancer symptoms. With statistics showing that one in two people will likely get cancer in their lifetime, this conversation emphasises why recognising early signs such as unexplained weight loss, excessive night sweats, new lumps, or persistent skin changes is vital for better outcomes. We also touch upon cultural barriers, especially within South Asian communities, and the impact of stigma and embarrassment in delaying diagnosis. Our goal is to reassure and encourage everyone to seek medical advice promptly for any concerning symptoms. For more information, visit nhs.uk/cancer-symptoms. Don't miss this informative and potentially life-saving discussion. 00:00 Understanding Cancer: Early Diagnosis and Survival Rates 00:58 Introduction to the Podcast and Guest 02:43 The NHS Help Us, Help You Campaign 04:14 Cultural Barriers and Embarrassment in Cancer Diagnosis 09:43 Early Signs and Symptoms of Cancer 14:23 Causes and Risk Factors of Cancer 16:32 Dietary Habits and Cancer Awareness in South Asian Communities 21:03 Understanding Cancer in Different Age Groups 21:42 The Complexity of Cancer Causes 23:17 Risk Factors and Screening Programs 25:24 The Importance of Early Detection 28:42 Cultural Barriers and Misconceptions 31:57 Encouraging Health Conversations in Families 34:48 General Health Advice and Prevention 37:50 Final Thoughts and Resources

Tuesday, April 8 -  Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health. First up, Doug and Dr. Ken start with some good news from the world of medicine with a simple smell test for early detection of Alzheimer's in an effort to treat the neurodegenerative disease early. Then, the conversation shifts to a focus between the connection between heart problems and brain diseases, evidence of animals and degenerative brain diseases, the FDA approves the first home-based nonprescription diagnostic test for certain STDs for women, sugar substitutes and why they aren't always a better alternative, children of obese mothers are more likely to become an obese adult, and the differences between the diabetes and weight loss drugs. Questioning why it's so difficult to find a doctor, and why there's such a long weight to get in with your medical team, the latest information on the Avian Flu, and changes in Medicaid affecting your wallet. Doug and Dr. Ken discuss that, too. Website: GoodDayHealthShow.com Social Media: @GoodDayNetworks

Updates in classification, evaluation, and treatment Become dexterous with dementia management! We're talking with Dr. Anna Chodos about cognitive domains, diagnostic criteria, patient and caregiver resources, new antibody therapies, and brain health plans!  Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Rapid fire questions The Terminology of Neurocognitive Disorders Cognitive Domains: A Comprehensive Approach Physical Examination Insights Medical Workup for Dementia Imaging and Biomarkers in Dementia Diagnosis Referral Considerations for Dementia Patients Understanding Dementia Stages and Prognosis Implementing Brain Health Plans Medications for Dementia Management Controversies in Monoclonal Antibody Therapies The Importance of Early Detection and Planning Outro Credits Producers, Writers and Show Notes: Leah Witt, MD and Margaret Heller, MD Infographic and Cover Art: Leah Witt, MD Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Emi Okamoto, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Anna Chodos, MD Disclosures Dr. Chodos received remuneration from Novo Nordisk for participating in a task force looking at the feasibility of incorporating biomarkers for Alzheimer's disease into primary care. The financial relationship has ended. The Curbsiders report no relevant financial disclosures.  The production of this episode was supported by the Penn Geriatrics AGE-SMART Geriatric Workforce Enhancement Grant. This podcast content is solely the responsibility of the authors and does not necessarily represent the official views of the Health Resources and Services Administration or the U.S. Department of Health and Human Services. Sponsor: Locumstory Locumstory.com is simply a free, unbiased educational resource about locum tenens.  Sponsor: Grammarly  Download Grammarly for free at Grammarly.com/PODCAST Sponsor: Continuing Education Company Special offer for Curbsiders listeners: Save 30% on all online courses and live webcasts with promo code CURB30. Visit www.CMEmeeting.org/curbsiders to explore all offerings and claim your discount. Whether live, online, or on-demand, Continuing Education Company makes earning CME easy and rewarding.

Dr. Joel Salinas, Co-Founder and Chief Medical Officer, and Dr. Julius Bruch, Co-Founder and CEO of Isaac Health, leverage virtual care and home visits to provide proactive, technology-enabled services for early diagnosis and treatment of dementia. Their mission is to reduce barriers to cognitive assessment and improve access to personalized care plans and treatments that can delay brain disease progression. The key is respecting the patient's decisions and building trust with the care team. Joel explains, "The first thing is really just meeting people where they're at. It's so hard to get access to high-quality care due to wait times and geographic reasons. What we're building at Isaac is meant to require zero distance and move a hundred times faster than the current care journey. The other piece is we develop these partnerships where we're much more proactive about identifying changes that someone might be having with memory or thinking. We are looking at risk factors that they may have within their health record and then actually doing some outreach to those who may have some undiagnosed cognitive impairment. Part of the goal here is by meeting people when their symptoms are at their earliest, we have an opportunity of really a golden window of time to be able to bring in interventions that can impact the long-term trajectory of their brain health." Julius elaborates, "We have built a very extensive technology platform that underpins the entire care journey, from identifying and screening patients to diagnosing, treating, and care management, and seeing as you specifically asked about the diagnosis part. So once we've identified that the member is at high risk, we reach out to them and enroll them in one of our programs. The first visit is generally a medical assessment, and we use a neuropsychologist who does that initial assessment. Still, our platform guides that whole interaction to make sure that we collect all the right information in the most efficient way possible. So it's still very much over Zoom because it is the most effective way to get to the information in this population. Our platform supports the whole care flow and makes sure that it's run as efficiently as possible." #IsaacHealth #BrainHealth #DementiaCare #Caregiversupport #GUIDEModel #DigitalHealth #HealthEquity #EarlyDetection #DigitalHealthcare #Telehealth #InnovativeHealthcare #PatientEmpowerment myisaachealth.com Download the transcript here

Dr. Joel Salinas, Co-Founder and Chief Medical Officer, and Dr. Julius Bruch, Co-Founder and CEO of Isaac Health, leverage virtual care and home visits to provide proactive, technology-enabled services for early diagnosis and treatment of dementia. Their mission is to reduce barriers to cognitive assessment and improve access to personalized care plans and treatments that can delay brain disease progression. The key is respecting the patient's decisions and building trust with the care team. Joel explains, "The first thing is really just meeting people where they're at. It's so hard to get access to high-quality care due to wait times and geographic reasons. What we're building at Isaac is meant to require zero distance and move a hundred times faster than the current care journey. The other piece is we develop these partnerships where we're much more proactive about identifying changes that someone might be having with memory or thinking. We are looking at risk factors that they may have within their health record and then actually doing some outreach to those who may have some undiagnosed cognitive impairment. Part of the goal here is by meeting people when their symptoms are at their earliest, we have an opportunity of really a golden window of time to be able to bring in interventions that can impact the long-term trajectory of their brain health." Julius elaborates, "We have built a very extensive technology platform that underpins the entire care journey, from identifying and screening patients to diagnosing, treating, and care management, and seeing as you specifically asked about the diagnosis part. So once we've identified that the member is at high risk, we reach out to them and enroll them in one of our programs. The first visit is generally a medical assessment, and we use a neuropsychologist who does that initial assessment. Still, our platform guides that whole interaction to make sure that we collect all the right information in the most efficient way possible. So it's still very much over Zoom because it is the most effective way to get to the information in this population. Our platform supports the whole care flow and makes sure that it's run as efficiently as possible." #IsaacHealth #BrainHealth #DementiaCare #Caregiversupport #GUIDEModel #DigitalHealth #HealthEquity #EarlyDetection #DigitalHealthcare #Telehealth #InnovativeHealthcare #PatientEmpowerment myisaachealth.com Listen to the podcast here

Listen to today's podcast... I had no idea. There will be nearly 9,000 new cases of Testicular Cancer diagnosed during this year and more than 300 young men will die from the disease because they didn't catch it in time. That is more deaths than women in this age group who will die of breast cancer.) Testicular Cancer is the most common cancer in men ages 15-40, that time when we don't want to admit the possibility of illness.  However, if detected early, it is among the easiest to cure. Take One Action Today To Build Your #Resiliency!      So Here are today's Tips For Building Resiliency and Celebrating Testicular Cancer Awareness Week: You are never too young or too old to do a self-exam.  Teach young boys just like we do teen girls to do a self-exam.  It should not be embarrassing, and it does save lives. Know the risk factors: Age: Most testicular cancers occur between the ages of 15 and 40. The main risk factor for testicular cancer are undescended testicle(s). A family history of testicular cancer increases the risk. Race and ethnicity: The risk of testicular cancer among white American men is about five times that of African-American men and more than double that of Asian-American men. Talk about it. Private parts are private, but knowing how to detect an illness early is just as essential as the ‘birds and the bees'. Discover how to take small steps towards a healthier, happier, less-stressed you by visiting my website at worksmartlivesmart.com #mentalhealth #hr

Did you know skin cancer is preventable, yet it's one of the most common cancers worldwide? In this inaugural episode of Season 2, we explore its causes, risk factors, and life-saving prevention tips to help you protect your skin and stay healthy.Welcome to Skin to It, the podcast where dermatologist Dr. Sandy Skotnicki and beauty enthusiast Marlo Sutton break down everything you need to know about healthy skin. In today's episode, we dive deep into skin cancer prevention, detection, and treatment, providing you with essential knowledge to protect yourself from this prevalent disease.What You'll Learn in This Episode:* Types of Skin Cancer: Learn about melanoma, basal cell carcinoma, and squamous cell carcinoma—what they are, their causes, and how to spot them early.* Skin Cancer Risk Factors: Discover how UV exposure, sun damage, and genetic predisposition increase your skin cancer risk.* Prevention & Protection: Understand the crucial role sunscreen, sun-protective clothing, and safe sun habits play in reducing your risk.* Early Detection: Learn how to check your skin at home, spot suspicious moles using the ABCDEs of melanoma, and why regular self-exams matter.* Treatment Advances: Explore the latest skin cancer treatment options, including surgery, immunotherapy, and radiation therapy.* Debunking Skin Cancer Myths: We separate fact from fiction, answering common questions like: Does dark skin need sunscreen? Can skin cancer spread quickly?* Living with Skin Cancer: Insights on oncology advancements, survival rates, and support for those diagnosed.By the end of this episode, you'll know how to prevent skin cancer, detect warning signs early, and explore the latest treatment options.Don't miss this life-saving conversation – tune in now.

In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Stephen Chan, Clinical Professor at the Department of Clinical Oncology of the Chinese University of Hong Kong, to discuss groundbreaking trials in hepatobiliary cancers, the role of diet in chronic liver disease, and the future of liver cancer care.  Timestamps:    00:00 – Introduction  02:09 – CARES-310 trial for liver cancer   4:33 – Camrelizumab + rivoceranib versus sorafenib  7:07 – Prevention and early detection of liver cancer   10:30 – Impact of lifestyle and diet on liver disease  12:38 – KEYNOTE-966 trial for biliary tract cancer  14:45 – Alternative strategies for liver cancer treatment  17:14 – Key initiatives of the International Liver Cancer Association  19:26 – Chan's three wishes for healthcare 

In this episode of SHE MD, hosts Mary Alice Haney and Dr. Thaïs Aliabadi welcome Kate Bond, an actress best known for her roles in Chicago Med, Good Trouble, and the reboot of MacGyver. For over a decade, Kate silently struggled with endometriosis, a chronic condition that affects millions of women but is notoriously difficult to diagnose. Her story highlights the frustrations many women face in the healthcare system when dealing with this condition and getting dismissed by most doctors. Kate and the hosts explore the challenges of her diagnosis, the impact on daily life, and the knowledge you need to be your own health advocate.Access more information about the podcast and additional expert health tips by visiting SHE MD Podcast and Ovii. Sponsors: One Skin: Visit OneSkin.co/SHEMD and use code SHEMD at checkout for 15% off your first purchasePurely Elizabeth: Visit purelyelizabeth.com and use code SHEMD at checkout for 20% off. Purely Elizabeth. Taste the ObsessionSaks.com: Shop Saks.coCymbiotika: Go to Cymbiotikia.com/SHEMD for 20% off your order + free shipping today.Zoe: As a ZOE member, you'll get an at home test kit and personalized nutrition program to help make smarter food choices that support your gut. That's ZOE.com and use code SHEMD10 to get 10% off your membership.Momentous: Go to livemomentous.com and try it today for 20% off with code SHEMD, and start living on purpose.iRestore: Reverse hair loss with @irestorelaser and get $625 off with code shemd at https://www.irestorelaser.com/SHEMD! #irestorepodKATE BOND'S TAKEAWAYS:Endometriosis symptoms often include severe pelvic pain, painful periods, and gastrointestinal issues that can significantly impact daily life and work.Proper diagnosis and treatment of endometriosis often require finding a doctor who listens, shows empathy, and is curious about solving the patient's health puzzle.Suppression therapy after endometriosis surgery is crucial for long-term management and prevention of symptom recurrence.Proactive health screenings, including genetic testing and colonoscopies, are important for early detection of related health issues, especially for those with endometriosis.Some endometriosis treatment includes laparoscopic surgery with an experienced surgeon who can diagnose and treat endometriosis; hormonal suppression, like progesterone IUDs, often helps manage symptoms; Dietary changes may be necessary to address related GI issues like SIBO.IN THIS EPISODE: (00:00) Intro(03:25) Kate Bond's endometriosis diagnosis journey(04:50) Dr. Aliabadi explains endometriosis in detail(09:52) Kate describes severe endometriosis symptoms(21:15) Endometriosis impacts career and life(24:50) Treatment options for endometriosis explained(29:08) SIBO and endometriosis connection discussed(33:54) Importance of early colonoscopy screening(42:35) Life improvements after endometriosis treatment(45:02) Endometriosis impact on family planningRESOURCES:Kate Bond's InstagramGUEST BIOGRAPHY:Kate Bond grew up in an A-frame house at the end of a long dirt road in rural Georgia. She is an actress whose credits include Chicago Med, Good Trouble, and the reboot of MacGyver. She's a passionate unionist and serves on the board of directors of the Los Angeles local of SAG-AFTRA. Her story isn't just about making it in the entertainment industry—it's about breaking through barriers, both systemic and personal, and redefining what success looks like when life throws you curveballs. For over a decade, Kate silently struggled with endometriosis, a chronic condition that affects millions of women but is notoriously difficult to diagnose. Like so many others, she was dismissed by doctors, told that her pain was “normal,” and forced to keep pushing forward—because when you're trying to build a career in Hollywood, there's no calling in sick.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode Summary:In this episode of the Beautifully Broken Podcast, Kyle Samuels—Founder & CEO of Creative Talent Endeavors (CTE)—opens up about his unexpected journey through a pancreatic cancer diagnosis and what it taught him about self-advocacy, resilience, and the importance of early detection. Kyle's story is a raw and inspiring look at how one moment can shift everything—and how listening to your body (and your loved ones) can literally save your life.Together, we explore his role as a disruptor in executive recruiting, the cultural disparities in healthcare, and the power of community when navigating illness. This is a conversation about hope, awareness, and the healing that happens when you embrace being beautifully broken.HIGHLIGHTS[2:52] Kyle breaks down what's broken in traditional recruitment and what he's doing differently [6:05] The Friday night that changed everything: Kyle's mysterious symptoms lead to a shocking discovery [12:05] Why early detection and a simple blood test (CA 19-9) may have saved Kyle's life [17:48] Navigating treatment and the mental/emotional recovery that follows [28:39] Proactive scanning: the game-changer in catching cancer early [30:28] Building the mental strength to handle unexpected health journeys [33:20] Talking about health inequities and why cultural shifts are needed [40:25] Health behavior and awareness in different communities [41:16] Gratitude, healing, and the new mission that emerged from the painCONNECT WITH KYLEWebsite: https://www.hirecte.com/LinkedIn: https://www.linkedin.com/in/kylesamuels/UPGRADE YOUR WELLNESSSilver Biotics Wound Healing Gel: https://bit.ly/3JnxyDD (30% off)(Use Code: BEAUTIFULLYBROKEN for Discount)Saga Bands: https://ca.saga.fitness/?ref=titvyccmCode: beautifullybrokenStemRegen: https://www.stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52Code: beautifullybrokenLightPathLED https://lightpathled.pxf.io/c/3438432/2059835/25794Code: beautifullybroken CONNECT WITH FREDDIE Check out my website and store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: (https://www.youtube.com/@BeautifullyBrokenWorld)

Breakthroughs in the Surgical Care of Thoracic Cancers and how Early Detection is Saving Lives with guest Dr. Dan Boffa March 30, 2025 Yale Cancer Center visit: https://www.yalecancercenter.org email: canceranswers@yale.edu

Early detection saves lives, and advanced treatments offer hope. Join Dr. C. Nikhil Kumar, Consultant Neurosurgeon, as he dives deep into understanding brain tumors, from recognizing warning signs to exploring cutting-edge medical breakthroughs. Hosted by Suhasini, this conversation is a must-listen for anyone seeking awareness and insight. Tune in to TALRadio on Spotify and Apple Podcast for this enlightening episode. Don't miss it!Host : SuhasiniGuest : Dr.Nikhil Kumaryou can reach Dr.Nikhil Kumar @linkedin.com/in/nikhil-kumar-7a66bb68#TALRadioEnglish #BrainTumorAwareness #Neurosurgery #EarlyDetection #AdvancedCare #DrNikhilKumar #HealthMatters #PodcastAlert #BrainHealth #MedicalInsights #ListenNow #InspiringTalks #TouchALife #TALRadio

In this standout episode of Next Steps 4 Seniors: Conversations on Aging, we’re bringing back an audience favorite: our eye-opening interview with Nurse Practitioner Liz Jackson from Henry Ford Hospital. Liz breaks down the B.E.F.A.S.T. method for spotting stroke symptoms early, dives into the different types of strokes, and explains why timing is everything when it comes to treatment. We also tackle the red flags of heart attacks, the sneaky signs of vascular disease (yes, even leg cramping!), and how managing conditions like high blood pressure and diabetes can be game-changers. Early detection = lives saved. This episode is packed with info that could protect you or someone you love. Listen now on your favorite podcast platform! Follow us on Facebook and Instagram @ConversationsOnAging Visit nextsteps4seniors.com and our foundation at nextsteps4seniorsfoundation.org Questions or ideas? Call 248-651-5010 or email hello@nextsteps4seniors.com Sponsorship inquiries: marketing@nextsteps4seniors.com Sponsored by Aeroflow Urology: You could qualify to receive incontinence supplies at no cost through insurance—discreetly delivered to your door. Visit aeroflowurology.com/ns4s to check eligibility. (*Some exclusions apply.)Learn more : https://nextsteps4seniors.com/See omnystudio.com/listener for privacy information.

Dr Charlie Andrews talks to Dr John Leeds. John Leeds is a Consultant Pancreaticobiliary Physician and Endoscopist based at the Freeman Hospital in Newcastle and an Honorary Clinical Senior Lecturer based in the Population Health Sciences Institute at Newcastle University. He is involved in research in pancreaticobiliary disorders including benign and malignant conditions as well as outcomes from therapeutic/advanced endoscopy.John is a member of the British Society of Gastroenterology and Pancreatic Society of Great Britain and Ireland. He serves on the endoscopy and Pancreas committees for BSG and is the website lead for PSGBI.He is also a founder member of the BSG Pancreas Clinical Research Group which is coordinating research for the society.Key Learnings from this episode:Challenges in Early Detection of Pancreatic Cancer • Pancreatic cancer is often diagnosed at an advanced stage due to the deep location of the pancreas and the lack of early symptoms. • Tumors in the body and tail of the pancreas can grow significantly before causing symptoms, often invading major arteries or veins, making them inoperable. • Tumors in the head of the pancreas may present earlier due to bile duct obstruction, leading to jaundice, but even these are often detected late. Early Symptoms and Red Flags • Early symptoms are vague or absent, making early diagnosis difficult. • Possible early indicators include: • Weight loss (often a sign of advanced disease). • New-onset diabetes, particularly in individuals with a normal BMI or without typical risk factors for type 2 diabetes. • Jaundice, which is a significant red flag and often indicates a serious underlying condition. • Classic signs like painless jaundice and Courvoisier's sign (palpable gallbladder) are important but not always present. Limitations of Current Screening Methods • There is no reliable biomarker or screening test for pancreatic cancer: • CA19-9 is not suitable as a screening tool due to its lack of specificity (elevated in other conditions). • Imaging techniques like CT scans or MRIs are used but have limitations, including incidental findings that may lead to unnecessary anxiety (“scanxiety”) and over-investigation. • Screening is currently limited to high-risk groups, such as those with familial pancreatic cancer syndromes or hereditary pancreatitis. High-Risk Groups for Screening • Familial pancreatic cancer accounts for less than 10% of cases. Criteria for screening include: • Multiple family members with pancreatic cancer, especially diagnosed under age 50–60. • Genetic syndromes like BRCA mutations, familial adenomatous polyposis (FAP), and Peutz-Jeghers syndrome. • Hereditary pancreatitis patients have an increased risk but are harder to screen due to pre-existing pancreatic abnormalities. Emerging Research and Future Directions • Studies are exploring potential biomarkers, such as microbiome signatures in the pancreas, which might help identify high-risk individuals in the future. • Trials like the EuroPAC study focus on surveillance protocols for high-risk individuals using imaging techniques like MRI or endoscopic ultrasound. • Research into new-onset diabetes as a potential marker for pancreatic cancer is ongoing but currently has a low yield due to the high prevalence of type 2 diabetes unrelated to malignancy. Considerations for Screening and Surveillance • Screening should be carefully targeted to avoid over-diagnosis and unnecessary investigations. • The psychological impact of screening (e.g., anxiety from incidental findings) must be considered. • Smoking cessation is emphasized as smoking is a significant risk factor for pancreatic cancer. Advances in Treatment Approaches • PET-CT scans are increasingly used to detect systemic disease that might not be evident on standard CT scans. • Neoadjuvant treatments (therapy before surgery) are being... Chapters (00:00:00) - Ingest(00:00:53) - Pancreatic Cancer(00:04:03) - New diabetes and pancreatic cancer(00:08:01) - Pancreatic Cancer: Screening(00:15:42) - Determining breast cancer early is hard(00:16:03) - Pulmonary neuroendocrine tumors of the pancreas(00:22:26) - Pancreatic cancer 20, Management(00:29:00) - Pancreatic cancer, management principles(00:33:48) - Primary Care Take Home: Pancreas, pain(00:40:29) - Primary Care: Pancreas Cancer Episode 2

Scott Hickle is the founder and CEO of Throne, a health tech startup building the world's first smart toilet to help people monitor their gut health, hydration, and urological function through passive, real-time data collection. With a background in engineering and product management, Scott blends deep technical knowledge with a mission-driven approach to preventative health. A Texas native and Austin-based builder, he's turning one of the last untapped frontiers of health data—the toilet—into a life-saving diagnostic tool. In this episode, Brett sits down with Scott Hickle, founder of Throne, to unpack one of the most ambitious healthtech missions in the game: building a toilet that could help prevent colon cancer, manage IBD, and transform gut health awareness. Scott shares how Throne evolved from a running joke to a startup with the potential to save lives. They dive deep into gut health, the cultural stigma around poop, and how stress, sleep, and food inputs impact digestion. Scott also shares takeaways from his ultra-processed food experiment and lessons from startup life—touching on energy, mission, and building in public. What we cover:- The Origin of Throne - The Gut as a Diagnostic Goldmine - Ultra-Processed Food Experiment - Building a Mission-Driven Startup Timestamps: (00:33) – How Throne was born (05:45) – From math failure to engineer (10:00) – Pain tolerance and entrepreneurship (27:55) – The smart toilet idea emerges (30:40) – Gut health starts in the toilet (36:00) – Why people ignore symptoms (44:50) – Tracking your gut in real time (52:00) – Preventing colon cancer early *** LINKS***Check out our Newsletter - Food for Thought - to dramatically improve your health this year!Join The Meat Mafia community Telegram group for daily conversations to keep up with what's happening between episodes of the show.Connect with Scott:InstagramThroneConnect with Brett:InstagramXConnect with Harry:InstagramXConnect with Meat Mafia:Instagram - Meat MafiaX - Meat MafiaYouTube - Meat MafiaConnect with Noble Protein:Website - Noble ProteinX - Noble ProteinInstagram - Noble ProteinAFFILIATESLMNT - Electrolyte salts to supplement minerals on low-carb dietThe Carnivore Bar - Use Code 'MEATMAFIA' for 10% OFF - Delicious & convenient Pemmican BarPerennial Pastures - Use CODE 'MEATMAFIA' 10% OFF - Regeneratively raised, grass-fed & grass-finished beef from California & MontanaFarrow Skincare - Use CODE 'MEATMAFIA' at checkout for 20% OFFHeart & Soil - CODE ‘MEATMAFIA' for 10% OFF - enhanced nutrition to replace daily vitamins!Carnivore Snax - Use CODE 'MEATMAFIA' Crispy, airy meat chips that melt in your mouth. Regeneratively raised in the USA.Pluck Seasoning - 15% OFF - Nutrient-dense seasoning with INSANE flavor! Use CODE: MEATMAFIAWe Feed Raw 25% OFF your first order - ancestrally consistent food for your dog! Use CODE 'MEATMAFIA'Fond Bone Broth - 15% OFF - REAL bone broth with HIGH-QUALITY ingredients! It's a daily product for us! Use CODE: MAFIAMaui Nui- 15% OFF. Use CODE: MEATMAFIA

Maureen McBeth, Senior Medical Affairs Liaison for ImpediMed, a company that develops bio-impedance spectroscopy technology for the early detection and monitoring of lymphedema. This swelling, a common side effect of breast cancer surgery, is often overlooked until it impacts the quality of life of the patient. Using this advanced diagnostic technology,  objective data on the risk and progression enables personalized intervention at the mild stage to prevent progression to severe, irreversible stages. Maureen explains, "Breast cancer-related lymphedema is an underappreciated side effect. Most people think that it's not an issue anymore because we do sentinel node biopsy. Still, we know that any time lymph nodes are removed, damaged, or radiated, they can cause problems with the plumbing system in that area of the body. And inflammation starts, and that's the first thing. People don't feel that, but over time, it starts to impact the lymphatic vessels, and those lymphatic vessels don't pump as well, and a fluid buildup starts to occur. Finally, a patient may start to have symptoms like an aching or a fullness, or they notice things don't fit right, and by the time they notice it, they're likely well into stage one lymphedema, which has noticeable symptoms." "And 20 years ago, when we didn't have these methods to detect it early, we often didn't see patients even with that at stage one. We wouldn't see them until the arm got really big and noticeable. If you can imagine, the guidelines said that the arm had to be 10% larger than the other side before we would diagnose it with lymphedema. Imagine your arm being 10% bigger on one side."  "One of the important things about our technology is that it's about a 30-second test. In terms of non-invasive, the patient doesn't feel it. It gives us this L-Dex score, and we can get other things like body composition. And so, at the start of someone's treatment, it can be used not only for surveillance of lymphedema but also for other side effects of cancer treatment." #ImpediMed #EarlyDetectionMatters #LymphedemaAwarenessMonth #Survivorship #SurvivorshipCare #PatientEmpowerment impedimed.com Download the transcript here

Maureen McBeth, Senior Medical Affairs Liaison for ImpediMed, a company that develops bio-impedance spectroscopy technology for the early detection and monitoring of lymphedema. This swelling, a common side effect of breast cancer surgery, is often overlooked until it impacts the quality of life of the patient. Using this advanced diagnostic technology,  objective data on the risk and progression enables personalized intervention at the mild stage to prevent progression to severe, irreversible stages. Maureen explains, "Breast cancer-related lymphedema is an underappreciated side effect. Most people think that it's not an issue anymore because we do sentinel node biopsy. Still, we know that any time lymph nodes are removed, damaged, or radiated, they can cause problems with the plumbing system in that area of the body. And inflammation starts, and that's the first thing. People don't feel that, but over time, it starts to impact the lymphatic vessels, and those lymphatic vessels don't pump as well, and a fluid buildup starts to occur. Finally, a patient may start to have symptoms like an aching or a fullness, or they notice things don't fit right, and by the time they notice it, they're likely well into stage one lymphedema, which has noticeable symptoms." "And 20 years ago, when we didn't have these methods to detect it early, we often didn't see patients even with that at stage one. We wouldn't see them until the arm got really big and noticeable. If you can imagine, the guidelines said that the arm had to be 10% larger than the other side before we would diagnose it with lymphedema. Imagine your arm being 10% bigger on one side."  "One of the important things about our technology is that it's about a 30-second test. In terms of non-invasive, the patient doesn't feel it. It gives us this L-Dex score, and we can get other things like body composition. And so, at the start of someone's treatment, it can be used not only for surveillance of lymphedema but also for other side effects of cancer treatment." #ImpediMed #EarlyDetectionMatters #LymphedemaAwarenessMonth #Survivorship #SurvivorshipCare #PatientEmpowerment impedimed.com Listen to the podcast here

Colorectal cancer is one of the most preventable cancers—when caught early. Yet, screening rates remain too low, and cases in younger adults are rising at an alarming rate. Disparities in access to screening also put certain communities at higher risk, making awareness and early detection more critical than ever. In this episode, we're joined by Dr. Reezwana Chowdhury, a leading gastroenterologist at Johns Hopkins and Chair of the American College of Gastroenterology's (ACG) Public Relations Committee. She's also a dedicated advocate for improving awareness in the South Asian community through her work with the South Asian IBD Alliance (SAIA). We cover: Who should get screened and when The rise in early-onset colorectal cancer The connection between IBD and colorectal cancer risk How screening can save your life This episode is presented in collaboration with the American College of Gastroenterology's Patient Care Committee.  

In a recent study published in JAMA Psychiatry, researchers reported that a machine learning model was able to stratify risk for subsequent diagnosis of schizophrenia or bipolar disorder among individuals already receiving psychiatric treatment. Coauthor Søren Dinesen Østergaard, PhD, of Aarhus University in Denmark joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss. Related Content: Machine Learning Model Shows Promise in Early Detection of Serious Mental Illness Predicting Diagnostic Progression to Schizophrenia or Bipolar Disorder via Machine Learning

Imagine this: 73 million Americans are over 65. Among them, 10-20% experience mild cognitive impairment (MCI), a potential precursor to Alzheimer's. Yet their primary care doctors, with only 14 minutes per patient, lack the time for crucial neurological screenings. This is a critical gap in our healthcare system, especially as groundbreaking Alzheimer's research and therapies emerge, making early detection more vital than ever. That's where Cx Precision Medicine comes in. In this episode, we sit down with Sid O'Bryant, PhD, and Danguole Altman, the team behind CxPM, a company in the StartUp Health Alzheimer's Moonshot Community working to revolutionize early cognitive screening with a simple blood test. Their innovative diagnostic tool is designed to detect neurodegenerative diseases earlier, ensuring patients get the right care at the right time. O'Bryant's extensive research, now commercialized by Altman's leadership, offers a powerful tool for personalized care, enabling earlier, more accurate diagnoses of neurodegenerative diseases. We'll dive into their unique journeys, the science behind their innovative blood test, and how it's poised to transform patient care.    Discover how Cx Precision Medicine is empowering patients to get the right care at the right time, streamlining the diagnostic process and ultimately, improving lives. Join us as we explore the future of Alzheimer's detection and the hope it brings. Let's get into it! Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Early detection is critical for improving cancer survival rates, yet pancreatic cancer remains challenging to detect. A recent breakthrough from Mayo Clinic researchers offers new hope. Artificial intelligence models demonstrate the potential to detect pancreatic cancer earlier and with remarkable accuracy. Learn more about this life-changing innovation in early cancer detection. Featured experts include Ajit Goenka, M.D., radiologist and professor of radiology at Mayo Clinic's Comprehensive Cancer Center and Suresh Chari, M.D., professor, Department of Gastroenterology, Hepatology, and Nutrition in the Division of Internal Medicine at MD Anderson Cancer Center.Get the latest health information from Mayo Clinic's experts, subscribe to Mayo Clinic's newsletter for free today:  https://mayocl.in/3EcNPNc

Early detection and monitoring of Type 1 Diabetes (T1D) are crucial for improving patient outcomes and quality of life. Join clinical experts Lubaina S. Presswala, DO, FACOI, FACE; Jeff Unger, MD, FAAFP, FACE, DACD; and Javier Morales, MD, FACP, FACE, as they discuss the growing prevalence of T1D, the importance of autoantibody screening, the different stages of T1D, screening guidelines, patient counseling, and how early intervention can help delay progression and reduce complications. Support for this podcast is provided by Sanofi.

In this captivating episode of the Dr. Geo Prostate Podcast, host Dr. Geo welcomes renowned cancer researcher Dr. Ralph Moss—a pioneer with over 50 years of experience—to discuss his innovative “three gears” approach to cancer treatment. Dr. Moss shares his personal journey through type 2 diabetes and prostate cancer, explaining how his experiences led him to develop the Moss Method, a natural and integrative approach to fighting cancer. The conversation navigates the interconnected roles of metabolism, immunology (with a special focus on the microbiome), and the emerging importance of cancer stem cells in disease progression. Listeners gain insight into cutting-edge diagnostics, the impact of diet and lifestyle on health, and how natural compounds like green tea, olive oil, and medicinal mushrooms may help target cancer at its roots. With a blend of personal narrative and scientific expertise, this episode offers practical advice and thought-provoking perspectives aimed at empowering individuals to take proactive steps toward better health.Key Highlights✔ Introduction to the Three Gears Dr. Geo introduces the episode's theme—metabolism, immunology, and cancer stem cells—as essential components of cancer treatment.✔ Dr. Ralph Moss's Background & Mission Overview of Dr. Moss's extensive career in integrative cancer research, including his personal battles with type 2 diabetes and prostate cancer, and his commitment to uncovering advanced, less toxic treatment strategies.✔ Metabolism, Immunology, and Cancer Stem Cells Explained The discussion centers on how these three elements interact in cancer development and treatment, highlighting the importance of addressing all facets for effective therapy.✔ Personal Health Journey & Diagnostic Innovations [00:05:00 – 00:09:00]Dr. Moss recounts his experiences with blood sugar management using continuous glucose monitors and draws a creative analogy with car diagnostics to illustrate advancements in health monitoring.✔ Dietary Approaches & Lifestyle Adjustments A deep dive into how a low-carb, keto-influenced diet helped manage his diabetes, along with discussions on the challenges of maintaining healthy blood sugar levels and the impact of sleep and exercise.✔ Early Detection & The Role of Nonconventional Tests Insights into his experience with unconventional diagnostic tests (like the Oncoblot) and the evolution of cancer detection, leading to a more personalized treatment strategy.✔ Integrative Cancer Strategies & The Moss Method Discussion of the Moss Method as a holistic framework that integrates dietary, immunological, and targeted natural therapies to combat cancer.✔ Immunology, Microbiome, and Natural Compounds Exploration of how a thriving microbiome and natural substances (such as kefir, sauerkraut, and specific mushrooms) support immune function and contribute to cancer prevention.✔ Cancer Stem Cells: The “Hidden Enemy” An in-depth look at cancer stem cells—their role in metastasis and treatment resistance—and why they represent a critical target in the fight against cancer.✔ Natural Strategies to Inhibit Cancer Stem CellsDiscussion on how natural compounds like green tea (EGCG), resveratrol, curcumin, and soy isoflavones can help block or eliminate cancer stem cells, with insights into their synergistic effects.----------------Thank you to our partnersThe ProLon 5-Day Fasting Mimicking Diet is a plant-based meal program designed to provide fasting benefits while allowing food intake. Developed by Dr. Valter Longo, it...

Join us as we navigate the evolving landscape of colorectal cancer (CRC ) screening. In this episode, our expert faculty Drs. Wendy Wright and Roseann Velez delve into the critical importance of early CRC detection — especially in younger patients. We'll explore the latest expert consensus guidelines, the array of screening tests available and the barriers to effective screening. With robust data and real-world insights, this podcast aims to empower nurse practitioners with knowledge and tools to improve CRC screening uptake and outcomes. Tune in to learn how proactive screening can save lives and reduce the burden of CRC. To claim 1.0 contact hours of continuing education (CE) credit for this program, (Early Detection Saves Lives: Navigating the Evolving Landscape of Colorectal Cancer Screening), search for this program by the title and complete the post-test and evaluation by entering the participation code given after listening to the podcast. This podcast was supported by an independent medical education grant from Exact Sciences. Download the patient handout here